Clinical Trial Update: Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)

View source ↗

Summary

The CARDIOTOX trial evaluating early assessment of anthracycline-induced cardiotoxicity has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Lymphoma

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Lymphoma, Heart Failure, Congestive | Status: TERMINATED